This phase 3 trial tests whether finerenone can reduce protein in the urine (proteinuria) of people who have had a kidney transplant. Proteinuria is a sign of kidney damage. The study compares finerenone plus standard care to dapagliflozin plus standard care in 54 adult patients.…
Phase: PHASE3 • Sponsor: kewen Chen,MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC